Onconetix, Inc.
ONCONasdaqHealthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|
| Revenue | $815,371 | $2.5M | $58,465 | — | — |
| Operating income | −$17.9M | −$56.5M | −$36.0M | −$13.5M | −$3.4M |
| Net income | −$14.0M | −$58.7M | −$37.4M | −$13.4M | −$3.4M |
| Total assets | $24.9M | $28.2M | $87.5M | $26.3M | $3.1M |
| Total liabilities | $9.2M | $18.6M | $21.9M | $3.9M | $1.6M |
| Equity | $15.8M | $8.5M | −$5.6M | $22.4M | $1.4M |
| EPS (diluted) | $-16.56 | $-1823.39 | $-87.45 | $-1.10 | $-1.26 |
| Shares out. | 44.4M | 22.3M | 15.9M | 15.3M | 3.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −2190.0%
- Net margin
- −1721.0%
- Return on equity
- −89.0%
- Return on assets
- −56.3%
- Return on capital (ROCE)
- −113.1%
- Liabilities / assets
- 36.7%
- Debt / equity
- 0.58×
- Book value / share
- $0.36
- Revenue growth (YoY)
- −67.7%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -20.98distress
- Accruals / assets
- −17.5%clean
- Beneish M-Score
- 27.96elevated
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 5 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Beneish M-Score elevated — earnings-manipulation screen flag
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2024
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2024
- NT 10-Qmissed a reporting deadline ↗May 15, 2024
- NT 10-Kmissed a reporting deadline ↗Apr 1, 2024
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2023
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Altos Venture AgActivist (13D)Jul 16, 2025
- Bruhlmann ChristianActivist (13D)Feb 14, 2025
- Schiess RalphActivist (13D)Feb 14, 2025
- American Financial Group IncPassive (13G)Feb 13, 2025
- Zurcher KantonalbankPassive (13G)Feb 7, 2025
- Scablis AgPassive (13G)Sep 27, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Hrt Financial Lp10% owner | Apr 21, 2026 | Sell | 49,710 | $0.69 |
| Hrt Financial Lp10% owner | Apr 16, 2026 | Sell | 53,867 | $0.73 |
| Hrt Financial Lp10% owner | Apr 14, 2026 | Buy | 74,350 | $0.77 |
| Oakley Andrew JohnDirector | Aug 15, 2025 | J | 20 | $0.00 |
| Tarsh SimonDirector | Aug 15, 2025 | J | 39 | $0.00 |
| Oakley Andrew JohnDirector | Mar 23, 2025 | Grant | 1,709 | $0.00 |
| Schiess RalphOfficer — Interim CEO, CSO | Dec 20, 2024 | Grant | 177,462 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 56,369 | 1.0 | -89.2% |
| Apr 30, 2026 | 522,813 | 1.0 | +128.4% |
| Apr 15, 2026 | 228,855 | 1.0 | -66.3% |
| Mar 31, 2026 | 680,001 | 1.0 | +161.3% |
| Mar 13, 2026 | 260,259 | 1.0 | +586.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Amended charter or bylaws · Other material eventMay 19, 2026
- Other material eventMay 14, 2026
- Shareholder voteMay 4, 2026
- Director / officer changeApr 24, 2026
- Amended charter or bylaws · Other material eventMar 27, 2026
- Director / officer changeMar 24, 2026
- Entered a material agreement · Other material eventFeb 12, 2026
- Shareholder voteFeb 9, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KCURRENT REPORTMay 19, 2026
- 8-KCURRENT REPORTMay 14, 2026
- 10-QQUARTERLY REPORTMay 13, 2026
- 424B3PROSPECTUSMay 12, 2026
- EFFECTMay 11, 2026
- EFFECTMay 7, 2026
- S-1/AAMENDMENT NO. 1 TO FORM S-1May 7, 2026
- POS AMPOST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1May 7, 2026
- 8-KCURRENT REPORTMay 4, 2026
- S-1REGISTRATION STATEMENTApr 28, 2026
- 8-KCURRENT REPORTApr 24, 2026
- 4PRIMARY DOCUMENTApr 22, 2026
- 4PRIMARY DOCUMENTApr 21, 2026
- 4PRIMARY DOCUMENTApr 16, 2026
- 3PRIMARY DOCUMENTApr 16, 2026
Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.